- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.02. | Morning Market Movers: Silicon Laboratories, Concorde International Group, ENvue Medical, Enphase Energy See Big Swings | 356 | AFX News | SUNNYVALE (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 30.01. | ENvue Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| ENVUE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 28.01. | ENvue Medical partners with U-Deliver to distribute ENFit syringes | 8 | Investing.com | ||
| 28.01. | ENvue Medical, Inc.: ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line | 8 | GlobeNewswire (USA) | ||
| 28.01. | EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal | 10 | Benzinga.com | ||
| 21.01. | ENvue Medical, Inc.: ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial | 4 | GlobeNewswire (USA) | ||
| 14.01. | ENvue Medical, Inc.: ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription | 5 | GlobeNewswire (USA) | ||
| 14.01. | EXCLUSIVE: Micro-Cap ENvue Medical Launches OTC Reusable Syringes For Feeding, Medication Delivery | 10 | Benzinga.com | ||
| 09.01. | ENvue Medical to develop vibration tech for nasogastric tube comfort | 2 | Investing.com | ||
| 09.01. | ENvue Medical, Inc.: ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research | 3 | GlobeNewswire (USA) | ||
| 08.01. | ENvue Medical, Inc.: ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 | 4 | GlobeNewswire (USA) | ||
| 30.12.25 | Envue Medical passt langfristigen Anreizplan an israelisches Steuerrecht an | 11 | Investing.com Deutsch | ||
| 23.12.25 | ENvue Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.12.25 | UK adds ENvue Medical's UroShield kit to NHS drug tariff | 3 | Investing.com | ||
| 18.12.25 | ENvue Medical, Inc.: ENvue Medical, Formerly NanoVibronix, UroShield Kit Secures Reimbursement in the UK | 2 | GlobeNewswire (USA) | ||
| 12.12.25 | NanoVibronix feeds into new focus on ENvue enteral system with rebrand | 4 | FiercePharma | ||
| 12.12.25 | NanoVibronix to rebrand as ENvue Medical, trade under FEED symbol | 3 | Investing.com | ||
| 12.12.25 | NanoVibronix, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.12.25 | NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and 'FEED' | 204 | Business Wire | New ticker symbol, "FEED" will begin trading on the Nasdaq at the open of the market on December 12, 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company")... ► Artikel lesen | |
| 05.12.25 | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 40,930 | +1,41 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Siemens Healthineers von 52,90 auf 52,15 Euro gesenkt, aber die Einstufung auf "Outperform" belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| BECTON DICKINSON | 149,20 | +0,09 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 10.02.2026 | Das Instrument 5FM NO0013637181 KMC PROPERTIES ASA NK 2 EQUITY wird cum Kapitalmassnahme gehandelt am 10.02.2026 und ex Kapitalmassnahme am 11.02.2026 The instrument 5FM NO0013637181 KMC PROPERTIES... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,019 | +4,35 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| SPINEWAY | 0,194 | +13,33 % | SPINEWAY: 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) | Ecully, January 13, 2026 - 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros20252024Change as a %H1 revenue5,5736,535-15%H2... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| LIFEWARD | 0,514 | +0,78 % | Lifeward Ltd. - 8-K, Current Report | ||
| NUWELLIS, INC | 1,970 | -7,08 % | Nuwellis, Inc.: Nuwellis Appoints Carisa Schultz as Chief Financial Officer | MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa... ► Artikel lesen | |
| LOGICMARK | - | - | LogicMark, Inc. Announces Third Quarter 2025 Results | LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc.?(OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and... ► Artikel lesen | |
| GLUCOTRACK | 1,660 | +1,84 % | Glucotrack, Inc.: Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform | RUTHERFORD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.("Glucotrack", or the "Company") (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization... ► Artikel lesen | |
| BONE BIOLOGICS | 1,230 | +2,50 % | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| MANGOCEUTICALS | 0,410 | +3,82 % | Mangoceuticals, Inc.: Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs | Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") is issuing the following clarification regarding its press release issued earlier... ► Artikel lesen | |
| FRESENIUS | 51,12 | +1,47 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
09.02.2026 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,890 | -0,24 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,840 | +1,33 % | Carl Zeiss Meditec: Ergebnisse brechen ein - neue Prognose kommt spätestens im Mai | Carl Zeiss Meditec ist mit einem deutlichen Ergebnisrückgang in das Geschäftsjahr 2025/2026 gestartet. Im ersten Quartal sank das EBITA auf 8,1 Millionen Euro nach 35,2 Millionen Euro im Vorjahreszeitraum.... ► Artikel lesen | |
| HEARTFLOW | 20,610 | -8,36 % | Heartflow, Inc.: Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 |
Das Unternehmen ENVUE MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 2,840 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVUE MEDICAL INC finden Sie auf Wallstreet Online.